Business
LifeStance Health Group, Inc. Announces Closing of Initial Public Offering
SCOTTSDALE, Ariz., June 14, 2021 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance Health" or the "Company"), one of the nation's largest providers
About this update from Lifestance Health Group, Inc.
[{"type":"text","content":"SCOTTSDALE, Ariz., June 14, 2021 /PRNewswire/ -- LifeStance Health Group, Inc. (\"LifeStance Health\" or the \"Company\"), one of the nation's largest providers of outpatient mental health care, today announced the closing of its initial public offering of 40,000,000 shares of its common stock at a public offering price of $18.00 per share. In the offering, the Company sold 32,800,000 shares and selling stockholders sold 7,200,000 shares. The underwriters have a 30-day option to purchase up to an additional 6,000,000 shares of common stock from the selling stockholders at the initial public offering price less underwriting discounts and commissions. LifeStance Health's common stock is listed on the Nasdaq Global Select Market under the ticker symbol \"LFST.\"\n\n \n \n \n \n \n \n\n \nMorgan Stanley, Goldman Sachs & Co. LLC, J.P. Morgan and Jefferies acted as lead book-runners for the offering. TPG Capital BD, LLC, UBS Investment Bank and William Blair acted as joint book-runners for the offering and Capital One Securities, AmeriVet Securities, Drexel Hamilton, R. Seelaus & Co., LLC and Siebert Williams Shank acted as co-managers for the offering.\nThis offering was made only by means of a prospectus. A copy of the final prospectus related to the offering may be obtained from: \nMorgan Stanley & Co. LLCAttention: Prospectus Department180 Varick Street, 2nd Floor, New York, NY 10014\nGoldman Sachs & Co. LLC Attention: Prospectus Department200 West Street, New York, New York 10282Phone: 1-866-471-2526 Fax: 212-902-9316 Email: [email protected]\nJ.P. Morgan Securities LLCc/o Broadridge Financial Solutions1155 Long Island Avenue, Edgewood, NY 11717Phone: 866-803-9204\nJefferies LLCAttention: Equity Syndicate Prospectus Department520 Madison Avenue, 2nd Floor, New York, NY 10022Phone: 1-877-821-7388Email: [email protected]\nA registration statement on Form S-1 relating to the sale of these securities was declared effective by the Securities and Exchange Commission on June 9, 2021. \nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such...